🇺🇸 FDA
Pipeline program

Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg

AM-PHN-004

Phase 3 small_molecule completed

Quick answer

Placebo of Phenazopyridine Hydrochloride Tables, USP 200 mg for Uncomplicated Urinary Tract Infections is a Phase 3 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Amneal Pharmaceuticals
Indication
Uncomplicated Urinary Tract Infections
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials